About: Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 April 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2008 (uk) im Juni 2008 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 28 April 2008 (en) artículu científicu espublizáu n'abril de 2008 (ast)
publication date	wds:Q60203750-B31F8A67-2E8E-49AB-AC6B-769BF593369C
publication date	2008-04-28 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60203750-0E4F0DEE-CB83-4D43-9ABE-334505DF95E9
language of work or name	English
author name string	wds:Q60203750-020F7FDE-51D6-4CE2-8E20-02DBB222AC00 wds:Q60203750-13FDBD0A-036F-4252-9686-C51EB47AA1E8 wds:Q60203750-1BFF978E-C4F5-49CA-86DD-72C01407F144 wds:Q60203750-344D70B1-87B5-4239-80C2-5E7C51957AFF wds:Q60203750-40BAC83C-71B1-4B99-BB0F-B9427DEA5420 wds:Q60203750-88DBA9A8-879A-4390-B361-37B9FD70545B wds:Q60203750-A2DA9873-BFA3-494D-A7A7-599DE1DDDE9D wds:Q60203750-E49854E7-84C2-4DD4-AE1E-D7BFD5A042F9
author name string	Rafael Martínez Anna Sureda Luis Palomera GEM Study Group Maria V Mateos Joaquín Diaz-Mediavilla José M Ojanguren PETHEMA Study Group
rdfs:label	Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (en) Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (nl)
skos:prefLabel	Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (en) Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (nl)
name	Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (en) Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy (nl)
author	wds:Q60203750-027DAA3A-9ECC-40D1-AAEF-89B8DBDBA266 wds:Q60203750-1D868E24-61C1-404E-A49A-B0553E05F972 wds:Q60203750-294D350A-2B36-4383-8198-90A5E27FF9B8 wds:Q60203750-41394545-BFFB-487E-8482-163D0F6BD1D2 wds:Q60203750-4E9EF23A-B8EC-4E31-A511-C6DF6F049BB7 wds:Q60203750-55EE3034-FB50-4096-8160-4E76E9535219 wds:Q60203750-89DBFB47-337F-4986-B9B7-8C2E05735E78 wds:Q60203750-A848EDC7-1583-4331-92FE-10770B95631B wds:Q60203750-D902E4B2-B4A5-4853-88FB-ACF7A55AFA15 wds:Q60203750-DBB1189A-388D-4C26-8348-F550B111E3E5 wds:Q60203750-DE58F7F1-8AEC-491B-8B72-233AC14B5185 wds:Q60203750-ED7FCF74-96BD-4FD7-9ACE-1F1BA29FA753 wds:Q60203750-F2FB0BD3-20E1-43A7-BB08-62831D8BBB16 wds:Q60203750-F3FD1BB2-0479-4951-A1A8-0F03A675D991
author	Norma C. Gutiérrez Alberto Orfao Laura Rosiñol Joan Bladé Javier de la Rubia Jesús San Miguel Josep-Maria Ribera Juan José Lahuerta Felipe de Arriba María-Belén Vidriales Maria José Terol Gema Mateo Laura Montejano Ma Angeles Montalbán
title	wds:Q60203750-7F0963DF-0007-4C9F-8090-75D6112CD0A7
title	Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy (en)
page(s)	wds:Q60203750-FB566E06-2E56-436E-8CBD-0B4708F8B5E3
page(s)	2737-2744
instance of	wds:Q60203750-E424DBBF-179B-4FCE-BD3E-97478E00155A
instance of	scholarly article
main subject	wds:Q60203750-9D7A499D-D08A-4FF6-8C1A-43010864FD6A
main subject	multiple myeloma
PubMed ID	wds:Q60203750-C65677FE-4BF9-42F9-9D01-063045F5CA84
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18443352
PubMed ID	18443352
published in	wds:Q60203750-642FC44D-3B09-40B8-B54F-A75961DD2164
published in	Journal of Clinical Oncology
issue	wds:Q60203750-A2EAC496-04C9-4582-9F42-0A535A23E25B
volume	wds:Q60203750-5906DA59-0F8C-4677-9C79-B726CA690398
issue	16
volume	26
DOI	wds:Q60203750-D500330B-A3BE-42AC-BB41-70F56F56D49F
DOI	http://dx.doi.org/10.1200/JCO.2007.15.4120
DOI	10.1200/JCO.2007.15.4120
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60203750
is cites work of	Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders Immunophenotyping in multiple myeloma and related plasma cell disorders CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software